Clinical Trial Update: AEF0217 in Participants With Down Syndrome [Phase 2]

View source ↗

Summary

Aelis Farma's Phase 2 trial of AEF0217 in participants with Down syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• AEF0217

Snippet

Sponsor: Aelis Farma | Conditions: Down Syndrome (Trisomy 21) | Phase 2 | Status: RECRUITING